
Delphi Ventures
About
Delphi Ventures Delphi Ventures is one of the longest-running healthcare-focused VCs in the US, founded in 1988 in San Mateo, California. Over more than two decades, the firm has committed over $1.1B across 8 funds and backed 170+ companies in biotechnology, medical devices, and health tech. The track record includes 2 unicorns, 10 IPOs, and 33 acquisitions, with Tandem Diabetes Care (diabetes management devices) among the more notable exits. The portfolio spans AEGEA Medical, EBR Systems, Sense
Industries
Stage focus
SeedSeries A
Geography
US
Notable investments
- Tandem Diabetes Care
- Karyopharm Therapeutics
- Revance Therapeutics
- PTC Therapeutics
- Alder Biopharmaceuticals
- Relypsa
Raising from Delphi Ventures?
I've worked with founders across the industrial stack. If Delphi Ventures is on your list, I can help you map the introduction path, sharpen the narrative, and run a tight process.
Talk to Dan